Rhinovirus-Induced Inflammation Linked to NLRP1 and IL-1 Pathways
Publication Title: Rhinovirus triggers distinct host responses through differential engagement of epithelial innate immune signaling
Summary
- Question
This study investigated how rhinoviruses (RVs), which cause the common cold and respiratory issues, trigger varying immune responses in the nasal epithelium, the tissue lining the nose. Researchers sought to understand the molecular mechanisms that lead to either effective virus control or excessive inflammation during RV infection.
- Why it Matters
RVs are the leading cause of common colds and exacerbate conditions like asthma and chronic obstructive pulmonary disease (COPD). While most infections are mild, RVs can cause severe respiratory distress in individuals at high-risk for respiratory infections. Understanding how nasal epithelial cells respond to RV could guide new treatments for managing inflammation and limiting severe outcomes, potentially benefiting public health, especially for individuals with respiratory conditions.
- Methods
- Researchers used a lab-grown model of human nasal epithelial cells, called air-liquid interface (ALI) cultures, which mimic the structure and function of the nasal lining. These cells were infected with RV under normal conditions and with pharmacological inhibitors that blocked specific immune pathways. Single-cell RNA sequencing (a technique that analyzes gene activity in individual cells) was performed to track immune responses at different time points.
- Key Findings
- The study found that a strong interferon (IFN) response—a critical antiviral defense—limited RV infection to less than 2% of cells. Blocking the IFN response caused a 40-fold increase in viral replication, widespread infection (affecting over 30% of cells), and heightened inflammation. This inflammatory response was driven by pathways involving nuclear factor κB (NF-κB) and Nod-like receptor protein 1 (NLRP1), leading to excessive mucus production and release of pro-inflammatory molecules like interleukin-1 beta (IL-1β). Disabling NLRP1 reduced inflammation, suggesting it as a potential therapeutic target.
- Implications
- These findings reveal that the nasal epithelium’s interferon response is crucial for controlling RV and preventing severe inflammation. However, when the IFN response is impaired, pro-inflammatory pathways dominate, leading to symptoms like airway obstruction and mucus overproduction, common in asthma and COPD exacerbations. Targeting the NLRP1 and IL-1 pathways could offer new therapeutic options for reducing inflammation in severe RV infections.
- Next Steps
- The authors recommend further research to explore therapies that modulate the NLRP1 and IL-1 pathways, aiming to reduce RV-induced airway inflammation. Additionally, studying these mechanisms in more complex systems, such as patient-derived tissues or clinical settings, could validate these findings and advance treatment development.
- Funding Information
- This research was supported by grants from the Yale Colton Center for Autoimmunity, the Rita Allen Foundation, and the China Scholarship Council Yale World Scholars Fellowship. Yale University also provided funding and support for this research.
Full Citation
Authors
Bao Wang
First AuthorEllen F Foxman, MD, PhD
Last AuthorAssociate Professor of Laboratory Medicine and Immunobiology